Related Experiment Video
Updated: Jun 19, 2026

07:06
Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients
Published on: March 29, 2022
E-prescribing in the optometric practice.
Summary
Electronic prescribing (e-prescribing) offers significant benefits for healthcare providers, including error reduction and improved patient compliance. Successful implementation requires practice-wide commitment, proper training, and addressing challenges for optimal adoption.
Area of Science:
- Health Informatics
- Optometric Practice Management
- Electronic Health Records
Background:
- E-prescribing presents opportunities for healthcare providers to enhance patient safety and streamline administrative processes.
- Adoption of new technologies like e-prescribing requires a learning curve and dedicated implementation efforts.
Purpose of the Study:
- To highlight the benefits of e-prescribing in optometric practices.
- To provide guidance on successful implementation and adoption of e-prescribing systems.
Main Methods:
- Review of e-prescribing benefits and implementation considerations.
- Reference to resources from the American Optometric Association (AOA) and the eHealth Initiative.
- Discussion of key factors for optimal practice experience with e-prescribing.
Main Results:
- E-prescribing can prevent medical errors, improve claims processing, and enhance patient adherence.
- Successful e-prescribing adoption hinges on leadership commitment, staff involvement, and adequate training.
- Current regulations prohibit the e-prescribing of controlled substances.
Conclusions:
- E-prescribing offers substantial advantages for optometric practices when implemented effectively.
- A holistic approach involving leadership, staff, patients, and vendors is crucial for maximizing e-prescribing benefits.
- Ongoing support and training are essential for users to become comfortable with the system.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
